The burgeoning biotech industry is built on modern scientific elements principally comprised of: genomics, genetics, immunology, molecular targeting and cell therapy. These therapeutics are increasingly designed to interact with a specific biochemical target in order to increase efficacy, reduce side effects, and produce an otherwise unattainable therapeutic benefit. These biotech drugs include: peptides, proteins, antibodies, vaccines, gene therapy and cell therapy. Most of these treatments are intravenous or injection, although R&D is taking place to find convenient oral or transdermal substitutes. The biotech sector cuts across industry, research institutes, academia, and hospitals across the world.